VISMO trial to treat basal cell carcinoma
22 Sep 2016
VISMO trial to treat basal cell carcinoma
Checkpoint inhibitor therapy for treating melanoma
Metabolomics: Reversing drug resistance
PDL1 and other biomarkers for selecting patients for immune checkpoint therapies
Editor's Choice for August 2016
Breaking down barriers to cancer communication worldwide
Drug repurposing in review
Tumour metabolism in chemoprevention
Bring patient voices into research
Patient advocacy in breast cancer research
Chemoprevention of breast cancer recurrence
Societal barriers to chemoprevention